Success requires AI that is customized, regulated, hybrid in its data structure and grounded at the deepest levels of the ...

Please give an overview of the recent compliance pressures that have been put on pharmaceutical companies. Compliance always has always been a high priority for data integrity in the pharmaceutical ...

With data as the new currency, the key to unlocking its full potential lies in strategic data management and innovative applications. Through its Intelligent Data Management Cloud, Informatica Inc.

Pharma companies are collaborating to boost the power of artificial intelligence (AI) in drug discovery by allowing access to ...

Information gleaned from organized data is one of a pharmaceutical business's most valuable resources. The key word in this statement is "organized," as free-flowing data is significantly different ...

In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

While pharma C-suite executives find themselves increasingly seduced by the promise of “digital transformation,” and especially by the idea of leveraging AI, the lived, on the ground reality within ...

Data is here to stay in pharma marketing. However, while most pharma companies have begun to use data to make marketing decisions, one healthcare agency data veteran sees a recurring problem in the ...

Commerce minister Piyush Goyal had recently said that data exclusivity could help attract R&D investments in the pharmaceuticals sector. However, data exclusivity to originator firms could facilitate ...

DUBLIN--(BUSINESS WIRE)--The "Efficient Batch Record Design and Review" training has been added to ResearchAndMarkets.com's offering. This online training is designed for professionals in the ...

BridgeBio Pharma announced it will present new open-label extension data from the ATTRibute-CM study, including 42-month results on cardiovascular mortality reduction, at the European Society of ...